66 related articles for article (PubMed ID: 17882962)
1. [Quality control methods and requirements for recombinant human lymphocyte function associated antigen 3 IgG1 fusion protein (rhLFA3-IgG1)].
Gao K; Han CM; Ding YX; Hou S; Rao CM; Wang JZ
Yao Xue Xue Bao; 2007 Jul; 42(7):762-7. PubMed ID: 17882962
[TBL] [Abstract][Full Text] [Related]
2. [Study on methods and requirements for quality control of recombinant human tumor necrosis factor receptor Fc fusion protein].
Zhang Y; Gao K; Han CM; Rao CM; Wang JZ
Yao Xue Xue Bao; 2003 Mar; 38(3):165-8. PubMed ID: 12830708
[TBL] [Abstract][Full Text] [Related]
3. [Study on methods for quality control of recombinant human neu epitope peptide 12].
Ji H; Wang JZ; Rao CM; Zhang Y; Wang M
Yao Xue Xue Bao; 2004 May; 39(5):359-62. PubMed ID: 15338879
[TBL] [Abstract][Full Text] [Related]
4. The effects of an immunomodulatory LFA3-IgG1 fusion protein on nonhuman primates.
Chisholm PL; Williams CA; Jones WE; Majeau GR; Oleson FB; Burrus-Fischer B; Meier W; Hochman PS
Ther Immunol; 1994 Aug; 1(4):205-16. PubMed ID: 7584496
[TBL] [Abstract][Full Text] [Related]
5. Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping.
Bongers J; Devincentis J; Fu J; Huang P; Kirkley DH; Leister K; Liu P; Ludwig R; Rumney K; Tao L; Wu W; Russell RJ
J Chromatogr A; 2011 Nov; 1218(45):8140-9. PubMed ID: 21978954
[TBL] [Abstract][Full Text] [Related]
6. A novel, rapid and sensitive heterotypic cell adhesion assay for CD2-CD58 interaction, and its application for testing inhibitory peptides.
Liu J; Chow VT; Jois SD
J Immunol Methods; 2004 Aug; 291(1-2):39-49. PubMed ID: 15345303
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation by LFA3TIP, an LFA-3/IgG1 fusion protein: cell line dependent glycosylation effects on pharmacokinetics and pharmacodynamic markers.
Meier W; Gill A; Rogge M; Dabora R; Majeau GR; Oleson FB; Jones WE; Frazier D; Miatkowski K; Hochman PS
Ther Immunol; 1995 Jun; 2(3):159-71. PubMed ID: 8885134
[TBL] [Abstract][Full Text] [Related]
8. Characterization of IgG1 immunoglobulins and peptide-Fc fusion proteins by limited proteolysis in conjunction with LC-MS.
Kleemann GR; Beierle J; Nichols AC; Dillon TM; Pipes GD; Bondarenko PV
Anal Chem; 2008 Mar; 80(6):2001-9. PubMed ID: 18293943
[TBL] [Abstract][Full Text] [Related]
9. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
[TBL] [Abstract][Full Text] [Related]
10. Functional glycan-free adhesion domain of human cell surface receptor CD58: design, production and NMR studies.
Sun ZY; Dötsch V; Kim M; Li J; Reinherz EL; Wagner G
EMBO J; 1999 Jun; 18(11):2941-9. PubMed ID: 10357807
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure/function analysis in vitro and in human CD2 transgenic mice.
Majeau GR; Meier W; Jimmo B; Kioussis D; Hochman PS
J Immunol; 1994 Mar; 152(6):2753-67. PubMed ID: 7511625
[TBL] [Abstract][Full Text] [Related]
12. Molecular dissection of the CD2-CD58 counter-receptor interface identifies CD2 Tyr86 and CD58 Lys34 residues as the functional "hot spot".
Kim M; Sun ZY; Byron O; Campbell G; Wagner G; Wang J; Reinherz EL
J Mol Biol; 2001 Sep; 312(4):711-20. PubMed ID: 11575926
[TBL] [Abstract][Full Text] [Related]
13. [Structure verification of a recombinant chimeric anti-CD20 IgG1 monoclonal antibody].
Tao L; Rao CM; Gao K; Shi XC; Zhao Y; Wang JZ
Yao Xue Xue Bao; 2010 Jun; 45(6):752-5. PubMed ID: 20939185
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods.
Li W; Yang B; Zhou D; Xu J; Li W; Suen WC
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation Modulates Human CD2-CD58 Adhesion via Conformational Adjustment.
Wang X; Ji CG; Zhang JZ
J Phys Chem B; 2015 Jun; 119(22):6493-501. PubMed ID: 25984915
[TBL] [Abstract][Full Text] [Related]
16. Heterotypic cell adhesion assay for the study of cell adhesion inhibition.
Satyanarayanajois SD; Ronald S; Liu J
Methods Mol Biol; 2011; 716():225-43. PubMed ID: 21318910
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Cellular Avidity Regulation in CD2-CD58-Mediated T Cell Adhesion.
Zhu DM; Dustin ML; Cairo CW; Thatte HS; Golan DE
ACS Chem Biol; 2006 Nov; 1(10):649-58. PubMed ID: 17168569
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouse/human chimeras.
Sultan P; Schechner JS; McNiff JM; Hochman PS; Hughes CC; Lorber MI; Askenase PW; Pober JS
Nat Biotechnol; 1997 Aug; 15(8):759-62. PubMed ID: 9255790
[TBL] [Abstract][Full Text] [Related]
19. Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12.
Gollob JA; Li J; Kawasaki H; Daley JF; Groves C; Reinherz EL; Ritz J
J Immunol; 1996 Sep; 157(5):1886-93. PubMed ID: 8757306
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of a new recombinant TNF receptor-hyFc fusion protein expressed in CHO cells.
Lee JH; Yeo J; Park HS; Sung G; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
Protein Expr Purif; 2013 Jan; 87(1):17-26. PubMed ID: 23009882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
